The polypill concept: The future

European Heart Journal

Volumn 32, Issue 22, 2011, Pages 2732-2733

  Jaques, Helen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS ANTIHYPERTENSIVE AGENT PLUS HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR POLYPILL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COUGHING; DRUG FORMULATION; ESOPHAGUS CANCER; HEART INFARCTION; HUMAN; INTESTINE CANCER; LUNG CANCER; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; STROKE; SURVIVAL; ARTICLE; FORECASTING; POLYPHARMACY;

CARDIOVASCULAR DISEASES; FORECASTING; HUMANS; POLYPHARMACY;

EID: 84856325297     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr370     Document Type: Note

References (7)

1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
2. Clinicaltrials.gov. International Clinical Trials Registry Platform. Fixed Dose Combination Drug (Polypill) for Secondary Cardiovascular Prevention (FOCUS). NCT01321255. 29 March 2011. http://clinicaltrials.gov/ct2/show/ NCT01321255.
3. Fixed Dose Combination Drug for Secondary cardiovascular Prevention. http://www.focus-fp7.eu/pages/homepage.php?lang=EN.
4. Clinicaltrials.gov. UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events. NCT01057537. http://clinicaltrials.gov/ct2/show/ NCT01057537.
5. The Single Pill to Avert Cardiovascular Events (SPACE) collaboration. http://www.spacecollaboration.org/.
6. Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-1351.
7. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.